Biotech Generics—A Pathway for Medication Savings.

The article reports that big health care savings can be attained if Food and Drug Administration would approve the generic biotechnology-derived medication in the U.S. It stated that a disproportionate share of growth in market share of the prescription drug segment has been experienced by the biotech pharmaceutical industry. An increase in market share has been imputed to high price premiums on biotech products and an increase in the number of diseases these products used to treat.